Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Meiogenix is a biotechnology company that develops breeding technologies.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Genomic Life offers genomic products.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
MOMA Therapeutics operates as a biotechnology company.
Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Casdin Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Relay Therapeutics received $200.0M in a Post Ipo Equity round. Casdin Capital's total known invested capital is $8.1B.
Casdin Capital's average investment size is $93.1M across its portfolio of 95 companies.
Recent Casdin Capital portfolio additions include Auron Therapeutics, A2 Biotherapeutics, Deepcell, Amplo Biotechnology, Umoja Biopharma. These companies were founded in 2020 or later.